Articles:

Thymidylate synthase inhibitors

N Touroutoglou and R Pazdur
Clin Cancer Res 1996 2: 227 [Abstract] [PDF]  

Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins

Y Reiter and I Pastan
Clin Cancer Res 1996 2: 245 [Abstract] [PDF]  

Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells

R Taetle, B Dos Santos, K Akamatsu, Y Koishihara, and Y Ohsugi
Clin Cancer Res 1996 2: 253 [Abstract] [PDF]  

bcl-2 protein expression correlates with recurrence and survival in early stage head and neck cancer treated by radiotherapy

O Gallo, V Boddi, A Calzolari, L Simonetti, M Trovati, and S Bianchi
Clin Cancer Res 1996 2: 261 [Abstract] [PDF]  

Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint

SP Howard, SJ Park, L Hughes-Davies, CN Coleman, and BD Price
Clin Cancer Res 1996 2: 269 [Abstract] [PDF]  

Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence

WD Tilley, G Buchanan, TE Hickey, and JM Bentel
Clin Cancer Res 1996 2: 277 [Abstract] [PDF]  

Phase I trial of 9-cis retinoic acid in adults with solid tumors

JM Kurie, JS Lee, T Griffin, SM Lippman, P Drum, MP Thomas, C Weber, M Bader, G Massimini, and WK Hong
Clin Cancer Res 1996 2: 287 [Abstract] [PDF]  

Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma

AA Jakubowski, DF Bajorin, MA Templeton, PB Chapman, BV Cody, H Thaler, Y Tao, DA Filippa, L Williams, ML Sherman, MB Garnick, and AN Houghton
Clin Cancer Res 1996 2: 295 [Abstract] [PDF]  

Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea

PA Philip, VL Souliotis, AL Harris, A Salisbury, AD Tates, K Mitchell, JH van Delft, TS Ganesan, and SA Kyrtopoulos
Clin Cancer Res 1996 2: 303 [Abstract] [PDF]  

Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration

P Lindner, D Heath, S Howell, P Naredi, and L Hafstrom
Clin Cancer Res 1996 2: 311 [Abstract] [PDF]  

Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study

JH Schiller, JA Hank, M Khorsand, B Storer, A Borchert, K Huseby-Moore, D Burns, O Wesly, MR Albertini, G Wilding, and PM Sondel
Clin Cancer Res 1996 2: 319 [Abstract] [PDF]  

Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a pediatric oncology group study

ML Graham, JJ Shuster, BA Kamen, VJ Land, MJ Borowitz, B Camitta, DL Cheo, MP Harrison, BG Leventhal, DP Pinkel, DJ Pullen, P Steuber, and VM Whitehead
Clin Cancer Res 1996 2: 331 [Abstract] [PDF]  

Quantitation of 5-fluorouracil catabolism in human liver in vivo by three-dimensional localized 19F magnetic resonance spectroscopy

CW Li, WG Negendank, KA Padavic-Shaller, PJ O'Dwyer, J Murphy-Boesch, and TR Brown
Clin Cancer Res 1996 2: 339 [Abstract] [PDF]  

Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings

RM Bukowski, T Olencki, H Gunn, D McLain, GT Budd, K Sandstrom, L Tuason, C Redovan, P Rayman, R Tubbs, D Resta, P Elson, and J Finke
Clin Cancer Res 1996 2: 347 [Abstract] [PDF]  

Intratumor pharmacokinetics, flow resistance, and metabolism during gemcitabine infusion in ex vivo perfused human small cell lung cancer

PE Kristjansen, TJ Brown, LA Shipley, and RK Jain
Clin Cancer Res 1996 2: 359 [Abstract] [PDF]  

PAK-104P, a pyridine analogue, reverses paclitaxel and doxorubicin resistance in cell lines and nude mice bearing xenografts that overexpress the multidrug resistance protein

U Vanhoefer, S Cao, H Minderman, K Toth, RJ Scheper, ML Slovak, and YM Rustum
Clin Cancer Res 1996 2: 369 [Abstract] [PDF]  

Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate

MA Carducci, JB Nelson, KM Chan-Tack, SR Ayyagari, WH Sweatt, PA Campbell, WG Nelson, and JW Simons
Clin Cancer Res 1996 2: 379 [Abstract] [PDF]  

Expression of bcl-2 and the progression of human and rodent prostatic cancers

Y Furuya, S Krajewski, JI Epstein, JC Reed, and JT Isaacs
Clin Cancer Res 1996 2: 389 [Abstract] [PDF]  

Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression

G Yang, AM Stapleton, TM Wheeler, LD Truong, TL Timme, PT Scardino, and TC Thompson
Clin Cancer Res 1996 2: 399 [Abstract] [PDF]  

Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum

M Lehnert, R de Giuli, and PR Twentyman
Clin Cancer Res 1996 2: 403 [Abstract] [PDF]  

Detection of K-ras mutations in lung carcinomas: relationship to prognosis

P Keohavong, MA DeMichele, AC Melacrinos, RJ Landreneau, RJ Weyant, and JM Siegfried
Clin Cancer Res 1996 2: 411 [Abstract] [PDF]  

Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content

AK El-Naggar, BL Kemp, N Sneige, KG Hurr, K Steck, ZN Tu, HA Fritsche, SE Singletary, and CM Balch
Clin Cancer Res 1996 2: 419 [Abstract] [PDF]  

Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines

M Yamada, A Tomida, H Yoshikawa, Y Taketani, and T Tsuruo
Clin Cancer Res 1996 2: 427 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.